BDBM50193860 4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-dimethyl-carbamimidoyl)-benzoylamino]-phenylsulfanyl}-benzoic acid::CHEMBL218528
SMILES: CN(C)C(=N)c1ccc(cc1)C(=O)Nc1ccc(Sc2ccc(cc2)C(O)=O)cc1C(=O)Nc1ccc(Cl)cn1
InChI Key: InChIKey=CUSCSOGEMCLGCL-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 (Homo sapiens (Human)) | BDBM50193860 (4-{3-(5-chloro-pyridin-2-ylcarbamoyl)-4-[4-(N,N-di...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Portola Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells | Bioorg Med Chem Lett 16: 5507-12 (2006) Article DOI: 10.1016/j.bmcl.2006.08.039 BindingDB Entry DOI: 10.7270/Q2SF2X05 | |||||||||||
More data for this Ligand-Target Pair |